相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review
Ilia Makedonov et al.
THROMBOSIS AND HAEMOSTASIS (2022)
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
Dominique Farge et al.
LANCET ONCOLOGY (2022)
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants
Paolo Prandoni et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban
Tatiane Ferreira et al.
VASCULAR PHARMACOLOGY (2020)
Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial
Pascale Notten et al.
LANCET HAEMATOLOGY (2020)
Prevention and Management of the Post-Thrombotic Syndrome
Ilia Makedonov et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial
Clive Kearon et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin
Rafael de Athayde Soares et al.
SURGERY (2019)
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis Analysis From a Stratified Multicenter Randomized Trial
Anthony J. Comerota et al.
CIRCULATION (2019)
Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism
Mette Sogaard et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Craig I. Coleman et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Epidemiology of the post-thrombotic syndrome
Jean-Philippe Galanaud et al.
THROMBOSIS RESEARCH (2018)
Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
K. K. Utne et al.
THROMBOSIS RESEARCH (2018)
Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
Stella Salta et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome
L. Jeraj et al.
THROMBOSIS RESEARCH (2017)
Vitamin K antagonists versus low-molecular-weight heparin for the long termtreatment of symptomatic venous thromboembolism
Alina Andras et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Compression therapy for prevention of post-thrombotic syndrome
Diebrecht Appelen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review
Yishu Yan et al.
CARBOHYDRATE POLYMERS (2017)
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
Amy L. Whitehead et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2016)
Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome
Kristin Kornelia Utne et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis A post-hoc analysis
Y. Whitney Cheung et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Heparin: Past, Present, and Future
Eziafa I. Oduah et al.
PHARMACEUTICALS (2016)
Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice
Tomoya Hara et al.
ATHEROSCLEROSIS (2015)
Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome
A. Rabinovich et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies A Scientific Statement From the American Heart Association
Susan R. Kahn et al.
CIRCULATION (2014)
Compression stockings to prevent post-thrombotic syndrome
Jean-Philippe Galanaud et al.
LANCET (2014)
New oral anticoagulant agents - general features and outcomes in subsets of patients
Sam Schulman
THROMBOSIS AND HAEMOSTASIS (2014)
An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database
Sophie A. M. Billingham et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH
W. Ageno et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
The history and historical treatments of deep vein thrombosis
J. -P. Galanaud et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: An update of the evidence
Russell D. Hull et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Non anticoagulant properties of heparin preparations: practical considerations
Claire Bal dit Sollier et al.
SANG THROMBOSE VAISSEAUX (2013)
Quality of life and economic costs associated with postthrombotic syndrome
Sumesh Kachroo et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2012)
Pharmacologic and Compression Therapies for Postthrombotic Syndrome A Systematic Review of Randomized Controlled Trials
Jacqueline M. Cohen et al.
CHEST (2012)
Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study
R. S. Chitsike et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
Tone Enden et al.
LANCET (2012)
Long-term Low-Molecular-Weight Heparin and the Post-Thrombotic Syndrome: A Systematic Review
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation
R. Guanella et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
Qianxing Zhou et al.
MEDIATORS OF INFLAMMATION (2011)
Tinzaparin Sodium A Review of its Use in the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism, and in the Prevention of Clotting in the Extracorporeal Circuit during Haemodialysis
Sheridan M. Hoy et al.
DRUGS (2010)
Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy
Matteo Ceccarelli et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization
S. R. Kahn et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin
Daria K. Moaveni et al.
JOURNAL OF VASCULAR SURGERY (2008)
Pain: a review of three commonly used pain rating scales
A Williamson et al.
JOURNAL OF CLINICAL NURSING (2005)
Evaluation of outcomes in chronic venous disorders of the leg: Development of a scientifically rigorous, patient-reported measure of symptoms and quality of life
DL Lamping et al.
JOURNAL OF VASCULAR SURGERY (2003)
分享论文
